CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Adeshwar Meditex Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Adeshwar Meditex Ltd
605, Niranjan, 99, Marine Drive
Phone: +91 2222674137p:+91 2222674137 MUMBAI, 400002  India Ticker: 543309543309

Business Summary
Adeshwar Meditex Limited is an India-based manufacturer and exporter of sterile surgical wound dressings and medical disposables. The Company also does job-work for various multi-national companies. The Company's product categories include sterile wound dressings, combine dressing, gauze dressing and cotton products, medical bandages and plaster, antiseptics/disinfectants, and other products. Its sterile wound dressings products include Bactigauze, Petronet/Para heal, Bactigauze Plus, Nitro heal, Pividine Povitulle, Povizole, Framitulle, Fusitulle, Calginate-AG Silvinet, Hydrasoothe, Polybane, Polybane-N and antiseptic wound care. The Company's antiseptics/disinfectants products include BIODEX-C - 2.45%, BIO CLEAN, VILON-N VILON Concentrated, Pividine - 5 % (Topical Solution), Pividine-S - 7.5 %, (Scrub), Pividine-C - 10 %, LYSOL I.P., BENZ VETOL 3% and BID QUAT 10%.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/20233/31/2023Yes----

General Information
Outstanding Shares: 14,431,426 (As of 9/30/2023)
Stock Exchange: BOM


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024